Q1 2021

Source filing unavailable

Q1 2021 · —

Revenue—

Net Income

-$2.36M

N/M vs Q1 2020

EPS Diluted

-$0.82

no prior Q1 2020 on file

Operating Income-$2,363,000—

Operating Cash Flow-$2,507,000—

Same quarter

Metric	Q1 2021	Q1 2020
Net Income	-$2.36M	-$1.69M
EPS Diluted	-$0.82	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR